Newly Diagnosed with Hormone-Positive Breast Cancer: Reading Your Pathology Report and Planning Integrative Support
A new HR+ breast cancer diagnosis comes with a pathology report full of numbers and unfamiliar terms. This article explains what ER, PR, HER2, Ki-67, and grade mean in plain language, and reviews the integrative support options with the strongest published evidence.
Newly Diagnosed with Leukemia: Questions to Ask Your Oncology Team and Integrative Care Planning
A leukemia diagnosis can require fast decisions and a rapid intake of unfamiliar information. This guide provides structured questions for your oncology team and an overview of how integrative care planning fits alongside conventional treatment.
Newly Diagnosed With Prostate Cancer: Should You Consider LDN as Part of Your Treatment Plan?
A prostate cancer diagnosis brings many decisions at once. This article reviews what the early evidence says about low-dose naltrexone (LDN) and what newly diagnosed patients should know before talking to their oncologist.
